Skip to main content

Table 1 Patient characteristics

From: A prediction model for the grade of liver fibrosis using magnetic resonance elastography

Characteristic

Patients (n = 184)

Age, yr

69 (42–91)

Male, n (%)

130 (70.6)

Background liver disease, n (%)

 Non-B non-C liver

103 (55.9)

 Hepatitis B

35 (19.0)

 Hepatitis C

46 (25.0)

Body mass index, kg/m2

22.8 (14.4–37.1)

ASA grading, n (%)

 Grade 1

65 (35.3)

 Grade 2

116 (63.0)

 Grade 3

3 (1.6)

History of hepatic resection, n (%)

48 (26.0)

Hemoglobin, g/dL

13.0 (8.2–16.9)

White blood cell count, 109/L

5.1 (2.3–12.1)

Platelet count, 109/L

17.2 (4.8–43.5)

Total bilirubin, mg/dL

0.59 (0.24–1.48)

Aspartate aminotransferase, U/L

28 (11–170)

Alanine aminotransferase, U/L

23 (6–271)

PT-INR

0.99 (0.85–1.36)

Albumin, g/L

3.9 (2.3–4.8)

Hyaluronic acid, ng/mL

62 (12–737)

IV core 7S, ng/mL

5.8 (3.2–13.0)

Child-Pugh classification, n (%)

 A

178 (96.7)

 B

6 (3.2)

ICGR15, %

12.2 (3.4–33.0)

LSM value by MRE, kPa

3.3 (1.4–11.2)

  1. Data were presented as median (range), if not specified
  2. ASA indicates American Society of Anesthesiology, PT-INR Prothrombin time-International normalized ratio, ICGR15 Indocyanine green clearance rate at 15 min, LSM Liver stiffness measurement, MRE Magnetic resonance elastography